| Carol A Gunnett, MD | |
|
1350 Boyson Road, Bldg C, Hiawatha, IA 52233 | |
| (319) 826-6773 | |
| (319) 826-6775 |
| Full Name | Carol A Gunnett |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 1350 Boyson Road, Hiawatha, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750326864 | NPI | - | NPPES |
| P01568811 | Other | IA | RR MEDICARE PROVIDER NUMBER |
| 1750326864 | Medicaid | IA | |
| R7788 | Other | IA | IA RESIDENT LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 37419 (Iowa) | Primary |
| 207Q00000X | Family Medicine | R7788 (Iowa) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Croix Hospice | Strawberry point, IA | Hospice |
| Guttenberg Municipal Hospital | Guttenberg, IA | Hospital |
| Regional Medical Center | Manchester, IA | Hospital |
| Guttenberg Care Center | Guttenberg, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guttenberg Municipal Hospital | 6901709476 | 20 |
News Archive
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
People being treated for bipolar disorder and other psychiatric illnesses are at greater risk of attempting suicide, but physicians may now have tools to predict which of those individuals will attempt it and intervene early to prevent such tragedies from occurring.
Mayo Clinic today announced an expansion to its sports medicine practice to meet the growing regional, national and international demand for its expertise.
The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.
AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Burlington, Vermont today and will offer free HIV testing, along with local partner Vermont Cares from 11:00 AM to 3:00 PM at the corner of Church St. and Main St. The testing will take place on AIDS Healthcare Foundation's new, state-of-the-art 'Testing America' mobile HIV testing unit named in honor of and in partnership with basketball legend Earvin "Magic" Johnson, Jr., as well as on the North Jersey AIDS Alliance mobile testing unit.
› Verified 4 days ago
| Entity Name | Guttenberg Municipal Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386679793 PECOS PAC ID: 6901709476 Enrollment ID: O20040130000960 |
News Archive
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
People being treated for bipolar disorder and other psychiatric illnesses are at greater risk of attempting suicide, but physicians may now have tools to predict which of those individuals will attempt it and intervene early to prevent such tragedies from occurring.
Mayo Clinic today announced an expansion to its sports medicine practice to meet the growing regional, national and international demand for its expertise.
The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.
AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Burlington, Vermont today and will offer free HIV testing, along with local partner Vermont Cares from 11:00 AM to 3:00 PM at the corner of Church St. and Main St. The testing will take place on AIDS Healthcare Foundation's new, state-of-the-art 'Testing America' mobile HIV testing unit named in honor of and in partnership with basketball legend Earvin "Magic" Johnson, Jr., as well as on the North Jersey AIDS Alliance mobile testing unit.
› Verified 4 days ago
| Entity Name | Guttenberg Municipal Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1932139359 PECOS PAC ID: 6901709476 Enrollment ID: O20061104000673 |
News Archive
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
People being treated for bipolar disorder and other psychiatric illnesses are at greater risk of attempting suicide, but physicians may now have tools to predict which of those individuals will attempt it and intervene early to prevent such tragedies from occurring.
Mayo Clinic today announced an expansion to its sports medicine practice to meet the growing regional, national and international demand for its expertise.
The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.
AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Burlington, Vermont today and will offer free HIV testing, along with local partner Vermont Cares from 11:00 AM to 3:00 PM at the corner of Church St. and Main St. The testing will take place on AIDS Healthcare Foundation's new, state-of-the-art 'Testing America' mobile HIV testing unit named in honor of and in partnership with basketball legend Earvin "Magic" Johnson, Jr., as well as on the North Jersey AIDS Alliance mobile testing unit.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carol A Gunnett, MD 1350 Boyson Road, Bldg C, Hiawatha, IA 52233 Ph: (319) 826-6773 | Carol A Gunnett, MD 1350 Boyson Road, Bldg C, Hiawatha, IA 52233 Ph: (319) 826-6773 |
News Archive
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
People being treated for bipolar disorder and other psychiatric illnesses are at greater risk of attempting suicide, but physicians may now have tools to predict which of those individuals will attempt it and intervene early to prevent such tragedies from occurring.
Mayo Clinic today announced an expansion to its sports medicine practice to meet the growing regional, national and international demand for its expertise.
The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.
AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Burlington, Vermont today and will offer free HIV testing, along with local partner Vermont Cares from 11:00 AM to 3:00 PM at the corner of Church St. and Main St. The testing will take place on AIDS Healthcare Foundation's new, state-of-the-art 'Testing America' mobile HIV testing unit named in honor of and in partnership with basketball legend Earvin "Magic" Johnson, Jr., as well as on the North Jersey AIDS Alliance mobile testing unit.
› Verified 4 days ago
Divya Narayanaswamy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 N Center Point Rd, Suite C, Hiawatha, IA 52233 Phone: 319-362-0200 Fax: 319-399-5186 | |
Matthew J Roes, D.C., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 754 N Center Point Rd, Hiawatha, IA 52233 Phone: 319-294-3263 | |
Regina A Torson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1095 N Center Point Rd, Hiawatha, IA 52233 Phone: 319-369-7914 Fax: 319-369-8726 | |
Dr. Michael James Franklin Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 Boyson Rd, Hiawatha, IA 52233 Phone: 319-743-7300 Fax: 319-743-7311 | |
Bradley Beer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 Blairs Ferry Rd, Hiawatha, IA 52233 Phone: 319-365-7521 Fax: 319-365-2839 | |
Brian David Ray, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S. Blairsferry Crossing, Suite A, Hiawatha, IA 52233 Phone: 319-393-0783 Fax: 319-393-0427 | |
Karen Harmon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 Blairs Ferry Rd, Hiawatha, IA 52233 Phone: 319-294-4967 Fax: 319-294-1194 |